LPA and familial hyperaldosteronism: Consequently, when participants with either phenotypical FH (probable or definite FH score) or elevated Lp(a) were grouped together, target attainment was significantly less likely (48.6% vs. 23.5%, p < 0.001) compared to participants with neither clinical FH (unlikely or possible) nor elevated Lp(a) levels (Fig. 3C).